Established in 2026, the Program is dedicated to cultivating regulatory science professionals with global perspectives, forward-looking thinking, and leadership capabilities in the field of medical products. Grounded in scientific principles, the Program emphasizes independent thinking and interdisciplinary integration, guiding students to address the rapidly evolving regulatory challenges arising from new healthcare models and technological innovation from a forward-looking perspective. Through systematic, science-based training and practice-oriented learning, the Program aims to develop graduates who are able to engage in evidence-informed planning and rational communication, and to serve as key contributors to the advancement of sound regulatory systems. By connecting academia, industry, and government, the Program seeks to strengthen the regulatory environment for medical products, safeguard public health, and promote the sustainable development of new drug research and innovative medical technologies under a robust and scientifically grounded regulatory framework.